INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $83,856,051 | -21.4% | 2,651,994 | +1.4% | 0.02% | -15.0% |
Q2 2023 | $106,654,544 | -3.5% | 2,615,364 | -11.8% | 0.02% | -9.1% |
Q1 2023 | $110,548,038 | +58.9% | 2,966,140 | +48.7% | 0.02% | +57.1% |
Q4 2022 | $69,577,221 | +116.1% | 1,994,188 | +246.6% | 0.01% | +100.0% |
Q3 2022 | $32,193,000 | -5.7% | 575,292 | -12.8% | 0.01% | 0.0% |
Q2 2022 | $34,156,000 | -39.6% | 659,899 | -15.2% | 0.01% | -30.0% |
Q1 2022 | $56,575,000 | -21.7% | 778,512 | +27.5% | 0.01% | -16.7% |
Q4 2021 | $72,215,000 | -7.8% | 610,748 | +4.6% | 0.01% | -7.7% |
Q3 2021 | $78,317,000 | +53.2% | 583,808 | +85.0% | 0.01% | +44.4% |
Q2 2021 | $51,106,000 | – | 315,641 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |